Proinflammatory cytokine levels are linked to death in pulmonary arterial hypertension

Cracowski Jean-Luc, Chabot François, Labarère José, Faure Patrice, Degano Bruno, Schwebel Carole, Chaouat Ari, Reynaud-Gaubert Martine, Cracowski Claire, Sitbon Olivier, Yaici Azzedine, Simonneau Gerald, Humbert Marc

Source: Eur Respir J 2014; 43: 915-917
Journal Issue: March
Disease area: Pulmonary vascular diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Cracowski Jean-Luc, Chabot François, Labarère José, Faure Patrice, Degano Bruno, Schwebel Carole, Chaouat Ari, Reynaud-Gaubert Martine, Cracowski Claire, Sitbon Olivier, Yaici Azzedine, Simonneau Gerald, Humbert Marc. Proinflammatory cytokine levels are linked to death in pulmonary arterial hypertension. Eur Respir J 2014; 43: 915-917

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The interleukin 13 receptor system is altered in pulmonary arterial hypertension
Source: Annual Congress 2006 - Lung vascular and parenchymal remodeling
Year: 2006


Inflammatory mediators contribute to pulmonary arterial cell dysfunction in a pulmonary arterial hypertension patient with BMPR2 mutation
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013

HIV-associated pulmonary arterial hypertension onset is associated with the soluble CD14 level and inflammation related to monocyte activation by LPS translocation from the gut
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015

MIF/CD74 contributes to the endothelial pro-inflammatory phenotype in pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013

Growth factors and interleukin-6 across the lung circulation in pulmonary hypertension
Source: Eur Respir J 2009; 34: 662
Year: 2009



IL-6 receptor overexpression in pulmonary arterial smooth muscle cells in idiopathic pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015

Regulation of inflammation process in chronic thromboembolic pulmonary hypertension: a potential role of platelet-activating factor-acetylhydrolase
Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling
Year: 2006


Inflammation in pulmonary arterial hypertension
Source: Eur Respir J 2003; 22: 358-363
Year: 2003



Inflammatory cytokines of patients with peripheral arterial disease and COPD
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010


Pro-inflammatory cytokines in pathogenesis professional occupetional pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 148s
Year: 2004

Monosodium urate crystals stimulate IL-6 production via TAK1 and induce pulmonary vascular dysfunction
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015

Cytokines and chemokines in pulmonary vascular remodelling
Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling
Year: 2005


Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension},
Source: Eur Respir J 2012; 40: 895-904
Year: 2012



Interleukin-13-dependent regulation of endothelin-1 expression in pulmonary arterial hypertension
Source: Annual Congress 2007 - Pulmonary hypertension
Year: 2007


Cellular sources of interleukin-6 and associations with clinical phenotypes and outcomes in pulmonary arterial hypertension
Source: Eur Respir J, 55 (4) 1901761; 10.1183/13993003.01761-2019
Year: 2020



Regulation of Type I cytokine receptors as a target for pulmonary arterial hypertension treatment?
Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension
Year: 2020


M2 macrophages derived from patients with idiopathic pulmonary arterial hypertension are susceptible for apelin-mediated suppression of pro-inflammatory cytokines
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014

Changing serum cytokines levels in patients with idiopathic pulmonary arterial hypertension treated with bosentan
Source: Annual Congress 2012 - Clinical management of lung diseases: from bronchi to pleura
Year: 2012

Serum levels of microRNA-125a are decreased in patients with precapillary pulmonary hypertension and correlate inversely with hemodynamics
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013

Endothelial-derived MIF contributes to pulmonary endothelial cell proliferation in human pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: promising small molecules
Year: 2015